The 20 Best Gastroesophageal Junction Cancer Doctors Near Me in New Hyde Park, NY

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Vinciguerra is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. Procaccino was born and raised in Westchester, New York. He graduated Summa Cum Laude from Manhattan College and was elected to Phi Beta Kappa. He went on to receive his Doctorate in Medicine from New York Medical College, and was elected to Alpha Omega Alpha in 1984. Dr. Procaccino relocated to Long Island in 1984 where he began his Internship in General Surgery at North Shore University Hospital. Once he completed his training in General Surgery, he trained as a fellow at the Cleveland Clinic. In 1998, he was asked to assume the role of Chief of Colon and Rectal Surgery at North Shore University Hospital in Manhasset.Dr. Procaccino has been the Director of North Shore University Hospital s Center for Colon and Rectal Diseases since inception. In this capacity, he was charged with the task of forming a Division of Colon and Rectal Surgery for the North Shore University Hospital and Long Island Jewish Hospital Department of Surgery. Dr. Procaccino soon took on the coveted position of Chief of this Division.Perhaps Dr. Procaccino s most significant contribution to the field of Colon and Rectal Surgery is his training of the next generation of surgeons. Since 2003, Dr. Procaccino has been the Director of the North Shore/LIJ Fellowship Program in Colon and Rectal Surgery which is accredited by the American Board of Colon and Rectal Surgery. Dr. Procaccino s clinical interests include Colon & Rectal Cancer, Inflammatory Bowel Disease (Crohn s and Ulcerative Colitis) and Diverticulitis. He performs both laparoscopic and open surgery. Dr. Procaccino is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, Ileostomy, and Hernia Surgery. Dr. Procaccino is board certified in American Board Of Surgery and American Board Of Colon & Rectal Surgery.

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is rated as an Advanced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Adult Soft Tissue Sarcoma, and Colorectal Cancer. Dr. Philip is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Advanced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy. Dr. Devoe is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Anna Levy DO, is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the Monter Cancer Center. Board certified in Internal Medicine, Hematology, and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Levy s scope of clinical practice includes liver, bile duct, esophageal, gastric, colon, rectal, and anal malignancies. She focuses on providing compassionate, personalized, and evidence based multidisciplinary care. Dr. Levy earned her medical degree at the Lake Erie College of Osteopathic Medicine. She trained in Internal Medicine at the Christiana Care Health System and completed her fellowship in Medical Oncology and Hematology at Long Island Jewish Medical Center. An active member of the American Society of Clinical Oncology, she is fluent in Russian. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, Pancreaticoduodenectomy, and Bone Marrow Aspiration. Dr. Levy is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Savona is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Sepideh Gholami is a Surgical Oncologist practicing medicine in Lake Success, New York. Dr. Gholami is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Pancreatic Cancer, Pancreatic Cancer, Hepatectomy, and Pancreaticoduodenectomy. Dr. Gholami is board certified in American Board Of Surgery and American Board Of Surgery/Complex General Oncology.

Kit Cheng, MD, is the Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she is committed to the recruitment and education of future generations of physicians. Board certified in Internal Medicine, Hematology and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As an attending physician based at the Monter Cancer Center, Dr. Cheng specializes in breast cancer and gynecology oncology, namely cervical cancer, endometrial cancer, ovarian cancer, uterine cancer and vaginal cancer. She is a principal investigator and sub principal investigator in multiple breast and gynecologic oncology clinical trials. She maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Cheng earned her medical degree at the State University of New York at Buffalo. She trained in Internal Medicine and Hematology/Oncology at North Shore University Hospital where she was also Chief Fellow. Dr. Cheng is an active member of the American Society of Clinical Oncology and is fluent in Cantonese and English. Dr. Cheng is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Cheng is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Rajiv Sharma is a Radiation Oncologist practicing medicine in Lake Success, New York. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Sharma is board certified in American Board Of Radiology/Radiation Oncology.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

"Matthew J. Weiss, MD, FACS, is deputy physician-in-chief and director of the surgical oncology program at Northwell Cancer Institute. He's a board-certified surgeon specializing in pancreas and liver diseases.With a relentless work ethic and strong desire to help people, Dr. Weiss always knew he wanted to be a doctor. ""I picked a field that allows me to tackle difficult problems and truly make an impact,"" he says.Dr. Weiss completed his residency in general surgery at Johns Hopkins Hospital and was dual fellowship trained in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center. He was previously chief of hepatobiliary surgery at Johns Hopkins, where he was also director of the Pancreas and Liver Multidisciplinary Clinics and the complex general surgical oncology fellowship. He also performed the first robotic Whipple at Johns Hopkins University. Joining Northwell in 2019, Dr. Weiss created a multidisciplinary team of surgeons, medical and radiation oncologists, geneticists, and other specialists who collaborate to create unique treatment plans for patients across the health system. ""Every cancer is different, and every patient is different,"" he says. ""Communication among multiple providers is the best way to ensure you're treating the entire person, properly,"" he says. Dr. Weiss's team also works with scientists from Cold Spring Harbor Laboratory and Feinstein Institutes for Medical Research to develop and run groundbreaking clinical trials. An international leader in both liver and pancreas surgery, Dr. Weiss has authored over 250 peer-reviewed publications in the field, and he's currently a professor of surgery and oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. ""Understanding both the science of the disease and the technological aspect of surgery is so important,"" he says. Dr. Weiss focuses on using cancer genetics to help find the right surgical approach for patients. When possible, he operates robotically using small incisions for faster healing, so patients don't have to wait as long to receive additional therapies that can improve outcomes. With recent advancements in the field, Dr. Weiss has been able to successfully perform high-risk surgeries that were turned down by other institutions. ""Being a surgeon is a tremendous responsibility, and I don't take it lightly,"" he says. ""I truly and deeply care about my patients and their families-I get to know them as people and am there throughout their entire journey. That's what I'm most proud of as a doctor.""". Dr. Weiss is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Hepatectomy. Dr. Weiss is board certified in American Board Of Surgery.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Sang Sim is an Internal Medicine specialist and a Radiation Oncologist practicing medicine in New Hyde Park, New York. Dr. Sim is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Endometrial Cancer.

Dr. Mark A. Hoffman is the Section Head of Hematology at Long Island Jewish's Division of Hematology/Oncology. Dr. Hoffman is also an Associate Professor of Clinical Medicine at Albert Einstein College of Medicine and was listed as one of the Best Doctors in America, from 2003 through 2007. His interests include breast cancer, gynecologic malignancies, chronic lymphocytic leukemia and malignant lymphomas. Dr. Hoffman is also focused on the development of communication skills in oncology and supportive care. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Endometrial Cancer, Adult Soft Tissue Sarcoma, and Inflammatory Breast Cancer.

President - New York Surgical SocietyPast President - New York society of Colon and Rectal Surgeons. Dr. Sher is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Gastrointestinal Bleeding, Hernia, Cholecystitis, Hernia Surgery, and Bladder Reconstruction. Dr. Sher is board certified in American Board Of Surgery and American Board Of Colon & Rectal Surgery.

Tereza Sardinha is a General Surgeon and a Colorectal Surgeon practicing medicine in New Hyde Park, New York. Dr. Sardinha is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Cholecystitis, Retroperitoneal Inflammation, Perianal Streptococcal Cellulitis, Hernia Surgery, and Bladder Reconstruction. Dr. Sardinha is board certified in American Board Of Surgery and American Board Of Colon & Rectal Surgery.

Mario Lacouture is a Dermatologist practicing medicine in Garden City, New York. Dr. Lacouture is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Autosomal Recessive Hypotrichosis, Hartsfield Syndrome, Alopecia Areata, and Basal Cell Skin Cancer.

Summa cum laude graduate of the University of Missouri in Columbia, MO. Honors graduate of the Saint Louis University School of Medicine in St. Louis, MO. Chief Resident and graduate of the Hofstra - Northwell Radiology Residency in Manhasset, NY. Graduate of the University of North Carolina Vascular and Interventional Radiology Fellowship in Chapel Hill, NC. Currently an Assistant Professor of Radiology at the Zucker School of Medicine at Hofstra/Northwell, and Attending Interventional Radiologist at North Shore University Hospital and Long Island Jewish - Valley Stream. Special areas of expertise include vascular malformations, lymphatic malformations, trauma, and bronchial artery interventions. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Ascites, Pleurisy, Pleural Effusion, Gastrostomy, and Liver Embolization. Dr. Al is board certified in American Board Of Radiology.

John Monson is a Colorectal Surgeon practicing medicine in Great Neck, New York. Dr. Monson is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Colostomy, and Ileostomy.

John Ricci is a Colorectal Surgeon practicing medicine in Great Neck, New York. Dr. Ricci is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Retroperitoneal Inflammation, Hernia Surgery, and Ileostomy. Dr. Ricci is board certified in American Board Of Surgery and American Board Of Colon & Rectal Surgery.